Immunotherapy: The key to a brighter future for cancer patients in Japan’s aging society?

YOKOHAMA – As the risk of cancer increases among the country’s aging population, immunologist Tasuku Honjo is pinning his hopes on cancer treatments that shift the approach from traditional methods directly targeting cancer cells to ones that stimulate the body’s immune system to fight the disease.

Nobel laureate Honjo, 77, believes his research can help bring about a cure — or at least turn cancer into a nonfatal chronic disease — but the jury is still out on whether immunotherapy can become a first-line treatment option.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s